| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3216199
Max Phase: Preclinical
Molecular Formula: C18H26Cl2N2O2
Molecular Weight: 300.40
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCNC(c1ccc(O)cc1)C(NCC)c1ccc(O)cc1.Cl.Cl
Standard InChI: InChI=1S/C18H24N2O2.2ClH/c1-3-19-17(13-5-9-15(21)10-6-13)18(20-4-2)14-7-11-16(22)12-8-14;;/h5-12,17-22H,3-4H2,1-2H3;2*1H
Standard InChI Key: BUXZIHYMOQAEFD-UHFFFAOYSA-N
Associated Targets(non-human)
Estrogen receptor 2172 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 300.40 | Molecular Weight (Monoisotopic): 300.1838 | AlogP: 3.10 | #Rotatable Bonds: 7 |
| Polar Surface Area: 64.52 | Molecular Species: BASE | HBA: 4 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 9.35 | CX Basic pKa: 8.78 | CX LogP: 2.57 | CX LogD: 1.49 |
| Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.63 | Np Likeness Score: 0.09 |
References
| 1. von Angerer E, Egginger G, Kranzfelder G, Bernhauer H, Schönenberger H.. (1982) N,N'-Dialkyl-1,2-bis(hydroxyphenyl)ethylenediamines and N,N-dialkyl-4,5-bis(4-hydroxyphenyl)imidazolidines: syntheses and evaluation of their mammary tumor inhibiting activity., 25 (7): [PMID:6809943] [10.1021/jm00349a013] |
Source
Source(1):